Europe's biggest Qualified Person Conference - 21st QP Forum
With Pre-Conference Sessions on 25 November 2026
26/27 November 2026, Barcelona, Spain
Course No. 22326
Speakers
David Cockburn
form. European Medicines Agency (EMA)
Dr Ulrich Kissel
European QP Association (EQPA), KisselPharmaConsulting
Dr Susanne Ding
Boehringer Ingelheim Pharma
Dr Afshin Hosseiny
ECA
Andreas Kraßnigg
AGES, Österreichische Agentur für Gesundheit und Ernährungssicherheit
Aidan Madden
FivePharma
Markus Roemer
comes compliance services
Dr Elke A. Loris
Merck
Sue Mann
Sue Mann Consultancy
Dr Rainer Gnibl
GMP Inspector
Dr. Monika Hupfauf
Attorney-at Law, Austria
Patryk Jegorow
Takeda
Cheryl Chia
Lotus Phoenix Consulting
Dr. Björn Cohrs
Landesamt für soziale Dienste des Landes Schleswig-Holstein
Ewa Rybak
Polpharma Biologics
Objectives
The QP at a Crossroads – Responsibility, Reform and Readiness for the Future.
The jubilee celebrations are behind us, but the challenges remain. And they are becoming more concrete.
Following the remarkable 50th anniversary of the Qualified Person (QP) and the 20th QP Forum last year, this year’s conference moves from reflection to action. The environment in which QPs operate is evolving rapidly. Legislative reform, digitalisation, AI-driven systems, and supply chain uncertainties are shaping our daily responsibilities.
Professionalism in the QP role has never been more important. It is no longer enough to rely on established practice. Continuous competence development, critical thinking, and proactive shaping of our professional standards are essential. The QP must remain an independent guardian of patient safety — but also a strategic quality leader in an increasingly digital and interconnected pharmaceutical world.
This year’s QP Forum provides the platform to address these pressing questions openly and constructively.
I look forward to welcoming you again — and continuing this important dialogue together.
Best regards, Ulrich Kissel Chairman of the European Qualified Person Association
Testimonials
